Osiris Therapeutics, Inc. Common Stock
OSIR
OSIR was delisted on the 16th of April, 2019.
63 hedge funds and large institutions have $114M invested in Osiris Therapeutics, Inc. Common Stock in 2014 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 23 increasing their positions, 20 reducing their positions, and 10 closing their positions.
15% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 20
6% less funds holding
Funds holding: 67 → 63 (-4)
10% less capital invested
Capital invested by funds: $127M → $114M (-$13.1M)
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
63% less call options, than puts
Call options by funds: $2.2M | Put options by funds: $5.92M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
+$16.9M |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$1.56M |
| 3 |
HNB
Huntington National Bank
Columbus,
Ohio
|
+$1.28M |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$1.26M |
| 5 |
QBFM
QS Batterymarch Financial Management
New York
|
+$755K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$4.14M |
| 2 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$2.29M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$1.73M |
| 4 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$1.09M |
| 5 |
ACM
Accipiter Capital Management
Palm Beach Gardens,
Florida
|
-$804K |
OSIR Hedge Fund Activity: Q1 2014 in Review
63 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Osiris Therapeutics, Inc. Common Stock (OSIR) for Q1 2014, worth a combined $114M — down 10% from $127M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of OSIR and 7 opened new positions — a net loss of 3 holders — while 20 trimmed existing stakes and 23 added.
The largest buyer was Consonance Capital Management, adding an estimated $16.9M. The largest seller was Lord, Abbett & Co, exiting entirely with an estimated $4.14M sold.
- 63 institutional investors held Osiris Therapeutics, Inc. Common Stock (OSIR) as of Q1 2014, down from 67 in Q4 2013.
- Funds reported $114M of Osiris Therapeutics, Inc. Common Stock stock for Q1 2014, down 10% quarter-over-quarter.
- 7 funds opened new Osiris Therapeutics, Inc. Common Stock positions in Q1 2014 and 10 closed out, a net change of -3 holders.
- The largest Osiris Therapeutics, Inc. Common Stock buyer in Q1 2014 was Consonance Capital Management, an estimated $16.9M added.
- The largest Osiris Therapeutics, Inc. Common Stock seller in Q1 2014 was Lord, Abbett & Co, an estimated $4.14M sold.
Based on aggregated 13F filings for Q1 2014.